Search

everythinglearnresearchcommunity

for

Search:↓

The US and EU lead in cell and gene therapy regulations with more approvals and clinical trials, while India is in early stages with fewer approvals and expedited processes.

Patients with limited English prefer professional language interpretation in otolaryngology clinics.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

The study's findings are unreliable due to retraction.

Intralesional corticosteroids are best for mild alopecia areata, and DPCP is best for severe cases.

Low-level red light therapy can shorten eye length in some myopic children.

Laser technologies improve medical treatments and outcomes.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

The IPL device is safe, effective, and has high patient satisfaction for hair removal.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Inflammasome proteins may help diagnose and treat Parkinson's disease.

Surgery for high-risk prostate cancer is challenging but doesn't lead to more complications, and additional treatment is often needed.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

Clascoterone is safe for the heart, even at high doses.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

High-content screening is useful for finding new treatments for rare diseases and has led to FDA-approved drugs.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Patients and doctors often agree on the severity of eyebrow and eyelash hair loss in severe alopecia areata.

The document does not provide information about hair loss treatment.

Methotrexate plus prednisolone had the fewest serious side effects.

Raman spectroscopy is promising for measuring and enhancing drug delivery in alopecia treatments.